Cargando…
Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study
In patients with stable coronary artery disease (CAD) blood hypercoagulability figures among factors leading to thrombosis. Tissue factor (TF) exposure at ruptured plaque initiates blood coagulation and hypercoagulability is responsible for thrombus formation. Early identification of patients eligib...
Autores principales: | Gerotziafas, Grigoris T., Zografos, Theodoros, Pantos, Ioannis, Lefkou, Eleftheria, Carlo, Audrey, Fareed, Jawed, Van Dreden, Patrick, Katritsis, Demosthenes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724406/ https://www.ncbi.nlm.nih.gov/pubmed/33284037 http://dx.doi.org/10.1177/1076029620964590 |
Ejemplares similares
-
Endothelial Cell Activation and Thrombin Generation Assessment for
the Risk of Severe Early Onset Preeclampsia. the ROADMAP-EOP
Study
por: Van Dreden, Patrick, et al.
Publicado: (2022) -
Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study
por: Gerotziafas, Grigoris T., et al.
Publicado: (2017) -
Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study
por: Van Dreden, Patrick, et al.
Publicado: (2021) -
Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?
por: Van Dreden, Patrick, et al.
Publicado: (2021) -
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
por: Chaari, Mourad, et al.
Publicado: (2014)